Epidemiology and pathophysiology of heart failure Margaret M. Redfield Clinical Trials Review Pages: 179 - 180
Ventricular unloading and myocyte recovery: Insight gained into the pathophysiology of congestive heart failure Kenneth B. Margulies OriginalPaper Pages: 181 - 188
The role of tumor necrosis factor alpha in the pathophysiology of congestive heart failure Charles F. McTiernanArthur M. Feldman OriginalPaper Pages: 189 - 197
Natriuretic peptides in the pathophysiology of congestive heart failure Horng H. ChenJohn C. Burnett Jr. OriginalPaper Pages: 198 - 205
Oxidative stress in congestive heart failure Pawan K. SingalNeelam KhaperAdriane Belló-Klein OriginalPaper Pages: 206 - 211
Failing energetics in failing hearts Petras P. DzejaMargaret M. RedfieldAndre Terzic OriginalPaper Pages: 212 - 217
Deactivation of the sympathetic nervous system in patients with chronic congestive heart failure Edward M. GilbertJ. David Port OriginalPaper Pages: 225 - 232
Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure Lasse Lehtonen OriginalPaper Pages: 233 - 243
Current management of patients with pulmonary hypertension and right ventricular insufficiency Shelley R. HankinsEvelyn M. Horn OriginalPaper Pages: 244 - 251
Selective or nonselective β-adrenergic blockade in patients with congestive heart failure Marco MetraSavina NodariLivio Dei Cas OriginalPaper Pages: 252 - 257
Therapeutic implications of escape from angiotensin-converting enzyme inhibition in patients with chronic heart failure Pierre Vladimir EnnezatMichael BerlowitzThierry H. Le Jemtel OriginalPaper Pages: 258 - 262